
Advanced Ovarian Cancer

Advanced Ovarian Cancer





HER2+ BC: Residual Disease After Neoadjuvant Therapy

Bassel El-Rayes, MD, discusses the key points physicians should consider when treating a patient with metastatic colorectal cancer.





Early HER2+ Breast Cancer





Multiple Myeloma

Noopur Raje, MD, discusses the current treatment options for patients diagnosed with multiple myeloma. At this time, a number of FDA-approved drugs and different combinations are available.






Case Based Peer Perspectives: Metastatic Castration-Resistant Prostate Cancer

Floor J. Backes, MD, discusses the side effects associated with the combination lenvatinib plus paclitaxel in patients with recurrent endometrial and platinum-resistant epithelial ovarian cancer.




